Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
Artificial Intelligence in Oncology

Division of Artificial Intelligence in Oncology

Prof. Dr. Moritz Gerstung

Maps of distinct breast cancer clones detected by Base-Specific In Situ Sequencing (http://dx.doi.org/10.1101/2021.04.16.439912)
© dkfz.de

The Gerstung lab investigates how tumours grow and change over time using AI and big data.

Cancer develops according to the rules of evolution — mutation and selection. Yet little is known about the timing of this process, the mechanisms by which mutations cause cancer cells to grow and how best to predict and influence the future course of this process.

Understanding these processes requires knowledge of large amounts of information at various scales. A cell’s genome comprises 6 billion base pairs of DNA. Thousands of genetic and epigenetic alterations of the DNA lead to a series of molecular cellular changes in each single cell. Further, tumours are an ecosystem of billions of mutant and normal cells that interact with each other via cellular contacts and signaling molecules.

Charting and modeling this information therefore requires sophisticated machine learning and AI algorithms. The primary focus of the lab is developing such algorithms and carrying out large scale data analyses to understand cancer evolution. The lab is also committed to contribute to generating genomic and molecular data at single and spatial resolution that form the basis of our research.

Specific research projects of the lab involve the establishment of a new spatial genomics platform for data generation and analysis. This will be key for decoding cancer evolution and unlock the secrets of the cancer ecosystem. We are also investigating how our knowledge about the natural history and origins of cancer can be used for early detection and cancer prevention. Lastly, the lab investigates how mutations arise in single cells to understand the very first steps of cancer development.

Contact

Prof. Dr. Moritz Gerstung
Artificial Intelligence in Oncology (B450)
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg

Selected Publications

  • AW Jung, PC Holm, K Gaurav, JX Hjaltelin, D Placido, LH Mortensen, et al. 2024. "Multi-cancer risk stratification based on national health data: a retrospective modelling and validation study." The Lancet Digital Health 6 (6), e396-e406
  • A Shmatko, AW Jung, K Gaurav, S Brunak, L Mortensen, E Birney, et al. 2024. "Learning the natural history of human disease with generative transformers." medRxiv, 2024.06. 07.24308553
  • A Lomakin, J Svedlund, C Strell, M Gataric, A Shmatko, G Rukhovich, et al. 2022. "Spatial genomics maps the structure, nature and evolution of cancer clones." Nature 611 (7936), 594-602
to top
powered by webEdition CMS